310 related articles for article (PubMed ID: 18298095)
1. Comparison of ligand-based and receptor-based virtual screening of HIV entry inhibitors for the CXCR4 and CCR5 receptors using 3D ligand shape matching and ligand-receptor docking.
Pérez-Nueno VI; Ritchie DW; Rabal O; Pascual R; Borrell JI; Teixidó J
J Chem Inf Model; 2008 Mar; 48(3):509-33. PubMed ID: 18298095
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening.
Pérez-Nueno VI; Pettersson S; Ritchie DW; Borrell JI; Teixidó J
J Chem Inf Model; 2009 Apr; 49(4):810-23. PubMed ID: 19358515
[TBL] [Abstract][Full Text] [Related]
3. Clustering and classifying diverse HIV entry inhibitors using a novel consensus shape-based virtual screening approach: further evidence for multiple binding sites within the CCR5 extracellular pocket.
Pérez-Nueno VI; Ritchie DW; Borrell JI; Teixidó J
J Chem Inf Model; 2008 Nov; 48(11):2146-65. PubMed ID: 18942828
[TBL] [Abstract][Full Text] [Related]
4. Highly specific and sensitive pharmacophore model for identifying CXCR4 antagonists. Comparison with docking and shape-matching virtual screening performance.
Karaboga AS; Planesas JM; Petronin F; Teixidó J; Souchet M; Pérez-Nueno VI
J Chem Inf Model; 2013 May; 53(5):1043-56. PubMed ID: 23577723
[TBL] [Abstract][Full Text] [Related]
5. Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening.
Kellenberger E; Springael JY; Parmentier M; Hachet-Haas M; Galzi JL; Rognan D
J Med Chem; 2007 Mar; 50(6):1294-303. PubMed ID: 17311371
[TBL] [Abstract][Full Text] [Related]
6. Biological profiling of anti-HIV agents and insight into CCR5 antagonist binding using in silico techniques.
Carrieri A; Pérez-Nueno VI; Fano A; Pistone C; Ritchie DW; Teixidó J
ChemMedChem; 2009 Jul; 4(7):1153-63. PubMed ID: 19544518
[TBL] [Abstract][Full Text] [Related]
7. Insight into the binding mode for cyclopentapeptide antagonists of the CXCR4 receptor.
Våbenø J; Nikiforovich GV; Marshall GR
Chem Biol Drug Des; 2006 May; 67(5):346-54. PubMed ID: 16784459
[TBL] [Abstract][Full Text] [Related]
8. Genotypic coreceptor analysis.
Sierra S; Kaiser R; Thielen A; Lengauer T
Eur J Med Res; 2007 Oct; 12(9):453-62. PubMed ID: 17933727
[TBL] [Abstract][Full Text] [Related]
9. Protein flexibility in ligand docking and virtual screening to protein kinases.
Cavasotto CN; Abagyan RA
J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
[TBL] [Abstract][Full Text] [Related]
10. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
[TBL] [Abstract][Full Text] [Related]
11. Impact of the CXCR4 structure on docking-based virtual screening of HIV entry inhibitors.
Planesas JM; Pérez-Nueno VI; Borrell JI; Teixidó J
J Mol Graph Model; 2012 Sep; 38():123-36. PubMed ID: 23079643
[TBL] [Abstract][Full Text] [Related]
12. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.
Evers A; Hessler G; Matter H; Klabunde T
J Med Chem; 2005 Aug; 48(17):5448-65. PubMed ID: 16107144
[TBL] [Abstract][Full Text] [Related]
13. Constitutive association of cell surface CCR5 and CXCR4 in the presence of CD4.
Wang J; Alvarez R; Roderiquez G; Guan E; Norcross MA
J Cell Biochem; 2004 Nov; 93(4):753-60. PubMed ID: 15660419
[TBL] [Abstract][Full Text] [Related]
14. Peptide, peptidomimetic and small-molecule drug discovery targeting HIV-1 host-cell attachment and entry through gp120, gp41, CCR5 and CXCR4.
Kazmierski WM; Kenakin TP; Gudmundsson KS
Chem Biol Drug Des; 2006 Jan; 67(1):13-26. PubMed ID: 16492145
[TBL] [Abstract][Full Text] [Related]
15. The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion.
Ablan S; Rawat SS; Viard M; Wang JM; Puri A; Blumenthal R
Virol J; 2006 Dec; 3():104. PubMed ID: 17187670
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
[TBL] [Abstract][Full Text] [Related]
17. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?
Bissantz C; Bernard P; Hibert M; Rognan D
Proteins; 2003 Jan; 50(1):5-25. PubMed ID: 12471595
[TBL] [Abstract][Full Text] [Related]
18. Targeting HIV-1 through molecular modeling and docking studies of CXCR4: leads for therapeutic development.
Singh S; Malik BK; Sharma DK
Chem Biol Drug Des; 2007 Mar; 69(3):191-203. PubMed ID: 17441905
[TBL] [Abstract][Full Text] [Related]
19. Optimization of high throughput virtual screening by combining shape-matching and docking methods.
Lee HS; Choi J; Kufareva I; Abagyan R; Filikov A; Yang Y; Yoon S
J Chem Inf Model; 2008 Mar; 48(3):489-97. PubMed ID: 18302357
[TBL] [Abstract][Full Text] [Related]
20. Improving virtual screening performance against conformational variations of receptors by shape matching with ligand binding pocket.
Lee HS; Lee CS; Kim JS; Kim DH; Choe H
J Chem Inf Model; 2009 Nov; 49(11):2419-28. PubMed ID: 19852439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]